Start-up pitch
The start-up pitch session is supported by INCATE and partners from the AMR community. Eleven finalists were selected that will have the opportunity to make a 5-minute-pitch of their venture in the start-up pitch session on 6 March. The best pitch will win a 10,000 € prize from award sponsor Vossius, one of the leading IP law firms in Europe.
-
Title
-
List Item
Proudly presenting the finalists
BrigGID Biologika
Developing novel, safe and life-saving anti-fungal therapies tailored for patients with complex co-morbidities.
Speakers: Soumya Palliyil
https://brigidbio.com
Theralia
TOUCAN Technology, as a unique oligonucleotide-based drug development platform, enables of using many potent but also toxic antimicrobial molecules, such as nucleoside analogues, safely in the treatment of infectious diseases by limiting their systemic side effects via precise delivery to the area of infection.
Speakers: Baris Ata Borsa
https://www.theralia.com